Serum 25-hydroxyvitamin D predict prognosis in radioiodine therapy of Graves’ disease

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of Endocrinological Investigation

• Publication date

  2015-03-04

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s40618-015-0252-4PMID 25736544
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes.

  2014cited by this paper
• Vitamin D supplementation: when and how?

  2014cited by this paper
• Vitamin D deficiency in patients with Graves’ disease: probably something more than a casual association

  2013cited by this paper
• High Failure Rates After 131I Therapy in Graves Hyperthyroidism Patients With Large Thyroid Volumes, High Iodine Uptake, and High Iodine Turnover

  2013cited by this paper
• Obstructive sleep apnea syndrome and its association with vitamin D deficiency

  2013cited by this paper
• Low serum vitamin D level is associated with high risk of metabolic syndrome in post-menopausal women

  2013cited by this paper
• Radioiodine therapy in Graves’ disease: Is it possible to predict outcome before therapy?

  2012cited by this paper
• Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves’ disease

  2012cited by this paper
• Serum vitamin D levels are decreased in patients without remission of Graves’ disease

  2012cited by this paper
• The incidence and prevalence of thyroid autoimmunity

  2012cited by this paper
• Relative Vitamin D Insufficiency in Hashimoto's Thyroiditis

  2011cited by this paper
• Randomized Trial of Alendronate Plus Vitamin D3 Versus Standard Care in Osteoporotic Postmenopausal Women with Vitamin D Insufficiency

  2011cited by this paper
• Thyrotropin receptor autoantibody measurement following radiometabolic treatment of hyperthyroidism: Comparison between different methods

  2010cited by this paper
• Vitamin D: modulator of the immune system.

  2010cited by this paper
• Impact of lithium on efficacy of radioactive iodine therapy for Graves' disease: a cohort study on cure rate, time to cure, and frequency of increased serum thyroxine after antithyroid drug withdrawal.

  2010influential reference
• Vitamin D deficiency modulates Graves' hyperthyroidism induced in BALB/c mice by thyrotropin receptor immunization.

  2009cited by this paper
• Optimal serum 25-hydroxyvitamin D levels for multiple health outcomes.

  2008cited by this paper
• TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study.

  2008cited by this paper
• Immunoregulation by 1,25-dihydroxyvitamin D3: basic concepts.

  2005cited by this paper
• High pre-therapy [99mTc]pertechnetate thyroid uptake, thyroid size and thyrostatic drugs: predictive factors of failure in [131I]iodide therapy in Graves' disease

  2005cited by this paper
• Vitamin D status, 1,25-dihydroxyvitamin D3, and the immune system.

  2004cited by this paper
• Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post‐therapeutic outcome

  2004cited by this paper
• Serum thyrotropin-receptor autoantibodies levels after I therapy in Graves' patients: effect of pretreatment with methimazole evaluated by a prospective, randomized study.

  2004cited by this paper
• The epidemiology of autoimmune diseases.

  2003cited by this paper
• How should the dose of iodine-131 be determined in the treatment of Graves' hyperthyroidism?

  2003cited by this paper
• High dose of (131)I therapy for the treatment of hyperthyroidism caused by Graves' disease.

  2002cited by this paper
• Vitamin D: its role and uses in immunology 1

  2001cited by this paper
• Radioiodine treatment of hyperthyroidism-prognostic factors for outcome.

  2001cited by this paper
• Clinical outcome after standardized versus dosimetric radioiodine treatment of hyperthyroidism: an equivalence study

  2000cited by this paper
• Outcome of thyroid function in Graves' patients treated with radioiodine: role of thyroid-stimulating and thyrotropin-blocking antibodies and of radioiodine-induced thyroid damage.

  1998cited by this paper
• Role of Cytokines in the Differentiation of CD4+ T‐Cell Subsets in vivo

  1991cited by this paper
• Differences and Similarities in the Diagnosis and Treatment of Graves' Disease in Europe, Japan, and The United States

  1991cited by this paper
• Blood lymphocyte population following 131I treatment for hyperthyroidism.

  1991cited by this paper
• Optimal iodine-131 dose for eliminating hyperthyroidism in Graves' disease.

  1991cited by this paper
• INFLUENCE OF TREATMENT WITH RADIOIODINE AND PROPYLTHIORACIL ON THYROID STIMULATING IMMUNOGLOBULINS IN GRAVES' DISEASE

  1980cited by this paper
• Influence of treatment with radioiodine and propylthiouracil on thyroid stimulating immunoglobulins in Graves' disease.

  1980cited by this paper

• A beneficial levels of 25-hydroxyvitamin D for a decrease in thyrotropin receptor antibody (TRAB) in patients with Graves’ disease: a real-world study

  2025cites this paper
• Association between serum vitamin D level and Graves’ disease: a systematic review and meta-analysis

  2024cites this paper
• The importance of vitamin d in the thyroid autoimmune diseases

  2023cites this paper
• Vitamin D and the Thyroid: A Critical Review of the Current Evidence

  2023cites this paper
• The Role of Vitamin D in Autoimmune Thyroid Diseases: A Narrative Review

  2023cites this paper
• Vitamin D status and cholecalciferol supplementation on patients with active Basedow disease: a clinical study

  2022cites this paper
• Vitamin D and Autoimmune Thyroid Disease—Cause, Consequence, or a Vicious Cycle?

  2020cites this paper
• Correlation of vitamin D level with thyroid status and TSH antibody titers in patients with Graves’ disease

  2020cites this paper
• Evaluation of Vitamin D Status and its Impact on Thyroid Related Parameters in New Onset Graves' Disease- A Cross-sectional Observational Study

  2019cites this paper
• A Weighted Genetic Risk Score Using Known Susceptibility Variants to Predict Graves Disease Risk.

  2019cites this paper
• 99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves' disease.

  2018cites this paper
• 99mTc-pertechnetate thyroid scintigraphy predicts clinical outcomes in personalized radioiodine treatment for Graves’ disease

  2018cites this paper
• The Effects of Vitamin D Supplementation on Thyroid Function in Hypothyroid Patients: A Randomized, Double-blind, Placebo-controlled Trial

  2018cites this paper
• Vitamin D and autoimmune thyroid diseases

  2017cites this paper
• Vitamin D in Graves Disease: Levels, Correlation with Laboratory and Clinical Parameters, and Genetics

  2017cites this paper
• Vitamin D and Graves’ Disease: A Meta-Analysis Update

  2015cites this paper